Alok Choksi
Biography
Alok Choksi is a counsel in the Corporate Practice Group in Haynes Boone’s New York office.
His practice focuses on capital markets and securities, representing investment banks, domestic issuers (including special purpose acquisition companies) and foreign private issuers in equity securities offerings, including registered offerings (such as initial public offerings, follow-on offerings, confidentially marketed public offerings, registered direct offerings and at-the-market program offerings) and private placements (such as 4(a)(2) offerings, PIPEs and 144A/Regulation S offerings). He works with companies in a wide range of industries, including aviation, biopharma, biotech, consumer/retail, education, energy, healthcare, media/telecommunications, oil and gas, shipping and technology, among others.
Alok Choksi is a counsel in the Corporate Practice Group in Haynes Boone’s New York office.
His practice focuses on capital markets and securities, representing investment banks, domestic issuers (including special purpose acquisition companies) and foreign private issuers in equity securities offerings, including registered offerings (such as initial public offerings, follow-on offerings, confidentially marketed public offerings, registered direct offerings and at-the-market program offerings) and private placements (such as 4(a)(2) offerings, PIPEs and 144A/Regulation S offerings). He works with companies in a wide range of industries, including aviation, biopharma, biotech, consumer/retail, education, energy, healthcare, media/telecommunications, oil and gas, shipping and technology, among others.
- The underwriters in connection with Joint Stock Company Kaspi.kz’s $1 billion IPO and listing on Nasdaq.
- The underwriters in connection with the $460.0 million equity follow-on offering of Intra-Cellular Therapies, Inc.
- Jefferies LLC, as sales agent, in connection with the establishment of the “at-the-market” (ATM) offering program relating to the issuance and sale of shares of common stock from time to time, having aggregate sale proceeds of up to $250.0 million for Wave Life Sciences Ltd.
- Barclays Capital Inc. and Cantor Fitzgerald & Co., as placement agents, in connection with the approximately $24.0 million registered direct offering of common stock, pre-funded warrants and warrants for Sangamo Therapeutics, Inc.
- Guggenheim Securities, LLC, as representative of the underwriters, on the $75.0 million equity follow-on offering for Chicken Soup for the Soul Entertainment, Inc.
- Oppenheimer & Co. Inc., as representative of the underwriters, on Backblaze, Inc.’s $115.0 million IPO.
- H.C. Wainwright & Co., LLC, as representative of the underwriters, in connection with the $35.0 million equity follow-on offering of common stock and warrants for SCYNEXIS, Inc.
- Gambling.com Group Limited and the selling shareholders in connection with the secondary only equity follow-on offering of approximately $40.0 million.
- Tufin Software Technologies Ltd. in connection with the secondary only equity follow-on offering of approximately $73.0 million.
- Oatly Group AB in connection with its US$430.0 million of financing commitments, consisting of a private placement of US$300 million convertible notes, and commitment letters for a US$130 million term loan B credit facility and a SEK 2.1 billion amended sustainable revolving credit facility.
Some of these representations were handled by Alok prior to joining Haynes Boone.
- Member, South Asian Bar Association of North America
- Adjunct Professor of Law, Vanderbilt Law School (2020 – 2022)
- "What you Should Know About Foreign Issuers and the PIPE Market," The PIPEs Conference, November 14, 2024.
Education
J.D., Vanderbilt Law School
M.S., Finance, Vanderbilt University
B.A., University of Pennsylvania, magna cum laude
Languages
Gujarati
Admissions
New York
Haynes Boone Advises Pulmatrix on Strategic Merger to Advance Biotech Innovation
November 13, 2024